An Q, Ma R, Yuan D, Huang J, et al. Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia. Clin Rheumatol 2024;43:1491-1501.
PMID: 38494557